跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-TADALAFIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-TADALAFIL
Authorized
STANDARD
M-TADALAFIL
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
55ac7f1c33dc2af7
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
55ac7f1c33dc2af7
Drug Approval Canada Name
M-TADALAFIL
Product Name
M-TADALAFIL
Status
Marketed
Status Date
2021-09-27
Original Market Date
2021-09-27
Din
02512122
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:12.12
Atc Original
G04BE08 TADALAFIL
Atc Name
g 04 be 08
Aig Number
0149485001
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
TADALAFIL
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
55ac7f1c33dc2af7
Type
Standard
Back to Health Canada Approvals